MECP2 and breast cancer: More recently, miR-22 that act as TS miRNA in wide variety of cancer such as colorectal cancer, gastric cancer, breast cancer, hepatocellular carcinoma and lung cancer, was shown to be subject to epigenetic regulation by methyl-CpG-binding protein 2 (MeCP2) in gastric cancer (108).